The global chemical peel market size was valued at USD 2.13 billion in 2025 and is projected to grow from USD 2.24 billion in 2026 to USD 3.38 billion by 2034, registering a CAGR of 5.26% during the forecast period from 2026 to 2034. North America dominated the chemical peel market with a market share of 38.4% in 2025.
A chemical peel is a cosmetic and dermatological skin-resurfacing treatment in which a chemical solution is applied to the skin to remove damaged outer layers and encourage the formation of smoother, healthier-looking skin. Depending on the formulation and treatment depth, chemical peels may be classified as superficial, medium, or deep.
Download a Free Sample To learn more about this report,
Growing Influence of Social Media on Chemical Peel Awareness
Social media platforms such as TikTok, Instagram, and YouTube are strongly influencing how consumers discover chemical peels and other exfoliating treatments. Before-and-after videos, skincare routines, dermatologist content, and influencer experiences are making professional and at-home peels more visible. At the same time, viral content is raising safety concerns because stronger chemical peels can cause burns, scarring, infection, and pigmentation changes when used incorrectly.
This viral case demonstrates the powerful role social media now plays in creating awareness and interest around chemical peel treatments. However, it is also increasing demand for professional guidance, safer formulations, clear usage instructions, and dermatologist-backed skincare education.
Growing Demand for Minimally Invasive Skin Treatments
Consumers are increasingly choosing non-surgical aesthetic procedures that address acne, pigmentation, uneven skin tone, fine lines, and texture without requiring lengthy recovery periods. Chemical peels fit this preference because treatments can be customized using different acids, concentrations, and application depths. Increasing awareness of professional skincare and greater availability through dermatology clinics and medical spas are supporting chemical peel market growth.
The development of targeted formulations is also helping practitioners treat a broader range of skin concerns and skin types, strengthening chemical peel market demand.
Growing clinical evidence and demand for less-invasive aesthetic treatments are supporting wider adoption of professional peeling procedures.
Potential Side Effects and Safety Concerns
Safety concerns remain an important restraint for the chemical peel market size, particularly when high-concentration products are used without professional supervision. Chemical peels can cause redness, swelling, irritation, and temporary peeling. Incorrect acid concentration, excessive exposure time, or unsuitable application can lead to more serious complications such as chemical burns, infection, scarring, and changes in skin pigmentation.
These risks are especially relevant to strong at-home products sold through online channels. The U.S. FDA has warned consumers against using certain high-concentration chemical peel products without supervision from a dermatologist or appropriately trained professional.
Growing awareness of these potential complications may make consumers more cautious about self-administered peels and increase the importance of professional guidance across the chemical peel industry.
Innovation in At-Home and Professional Peel Formulations
Product innovation is creating opportunities for brands to combine chemical exfoliation with enzymatic, physical, hydrating, and skin-conditioning technologies. These formulations can provide consumers with more convenient treatment options while allowing professional skincare companies to extend their expertise beyond dermatology clinics and aesthetic centers.
At-home products inspired by professional treatments are becoming important chemical peel market trends, particularly among consumers seeking manageable exfoliation routines between professional appointments.
Such innovations can help skincare brands reach new consumer groups and strengthen their chemical peel market share through differentiated treatment formats.
Balancing Treatment Effectiveness with Sustainability
Chemical peel manufacturers face the challenge of delivering effective exfoliation while responding to growing expectations for sustainable and traceable cosmetic ingredients. Glycolic acid is widely used in professional and consumer peeling formulations, but conventional production has historically depended heavily on petrochemical feedstocks.
Moving toward alternative ingredients requires manufacturers to maintain purity, consistency, performance, regulatory compliance, and commercial-scale availability. This can make reformulation and sustainable sourcing more complex for skincare companies.
The transition toward more sustainable active ingredients presents long-term potential, but maintaining performance and reliable commercial supply while changing established formulations remains a challenge for peel manufacturers.
Salicylic Acid Peel Segment Dominated the Market with 24.6% Share in 2025
The salicylic acid peel segment dominated the global chemical peel market with a 24.6% share in 2025, valued at USD 0.52 billion. Salicylic acid is widely used in superficial chemical peeling because of its exfoliating properties and ability to penetrate oily skin. It is commonly used in professional skin-care settings to address acne-prone skin, clogged pores, uneven texture, and certain pigmentation concerns. Its established use in dermatology and suitability for controlled superficial peeling continue to support demand.
The trichloroacetic acid peel segment remains significant as TCA can be used at different concentrations for concerns such as uneven pigmentation, signs of photoaging, and selected scars. Treatment depth and recovery requirements vary according to concentration and application.
Pigment balancing peels are projected to register the fastest growth at a CAGR of 9.1%. Growing demand for customized treatments addressing uneven skin tone and pigmentation concerns is supporting greater interest in tailored chemical peel formulations.
Request Customizationto receive a tailored report.
Superficial or Light Peel Segment Dominated the Market with 62.7% Share in 2025
The superficial or light peel segment dominated the global market with a 62.7% share in 2025, valued at USD 1.34 billion. These peels primarily target the outer layers of the skin and are commonly selected for concerns such as mild acne, uneven skin tone, rough texture, and superficial pigmentation. Their relatively shorter recovery period compared with deeper procedures makes them suitable for consumers seeking less intensive professional skin treatments.
Medium peels remain important for more noticeable pigmentation changes, wrinkles, and selected acne scars. As these treatments penetrate deeper into the skin, they generally involve greater recovery requirements than superficial peels.
Deep or phenol peels represent a smaller segment because they are substantially more intensive and require careful patient selection and professional medical supervision. They are generally considered for more significant skin concerns where deeper resurfacing is appropriate.
Acne Spots Segment Dominated the Market with 19.4% Share in 2025
The acne spots segment dominated the global chemical peel market with a 19.4% share in 2025, valued at USD 0.41 billion. Chemical peels are commonly used in dermatology to exfoliate the skin and support treatment approaches for certain forms of acne and post-acne concerns. Salicylic, glycolic, and other superficial peeling agents are used according to skin condition and treatment requirements.
Hyperpigmentation is projected to register the fastest growth at a CAGR of 9.2%. Increasing demand for treatments addressing uneven pigmentation, post-inflammatory marks, and visible discoloration is supporting the use of professionally selected peeling agents.
Skin brightening is also gaining demand as consumers seek professional treatments to improve dullness, uneven tone, and overall skin appearance. Chemical peels are often incorporated into broader skin-care programs depending on individual skin type and treatment goals.
Dermatology Clinics Segment Dominated the Market with 37.2% Share in 2025
Dermatology clinics dominated the global market with a 37.2% share in 2025, valued at USD 0.79 billion. Chemical peeling requires careful selection of the peeling agent, concentration, treatment depth, and application time according to the patient's skin type and concern. Dermatology clinics provide professional assessment and access to trained practitioners, supporting their leading position for treatments addressing acne, pigmentation, photoaging, and other skin concerns.
Med spas represent another major end-user and are projected to register the fastest growth at a CAGR of 9.1%. Growing consumer demand for minimally invasive aesthetic procedures and professionally administered skin treatments is supporting chemical peel adoption across these facilities.
Hospitals continue to provide chemical peeling within dermatology and aesthetic-care departments, particularly when patients require broader medical evaluation or treatment alongside other dermatological procedures.
Speak to an Analystto discuss market opportunities.
North America chemical peel market accounted for 38.4% of the global market, reaching USD 0.82 billion in 2025, and is projected to grow at a CAGR of 7.2% during the forecast period. Growth is supported by high consumer spending on aesthetic procedures, widespread availability of dermatology and medical aesthetic clinics, and growing interest in minimally invasive skin treatments. Chemical peels continue to be used for concerns such as uneven pigmentation, acne-related marks, fine lines, sun damage, and skin texture, supporting consistent demand across the region.
The US market was valued at USD 0.70 billion in 2025, making it the largest contributor in North America. A large network of dermatologists, plastic surgeons, medical spas, and aesthetic clinics supports widespread access to professional chemical peel procedures. Increasing consumer interest in skin rejuvenation and personalized aesthetic treatments, along with greater availability of superficial and medium-depth peels, continues to strengthen market demand.
Canada's market reached USD 0.09 billion in 2025. Growing consumer spending on professional skincare, expanding availability of medical aesthetic clinics, and rising awareness of treatments for pigmentation, acne-related concerns, and signs of skin aging are supporting demand. Consumers are also showing greater interest in minimally invasive procedures that generally require less recovery time than surgical cosmetic treatments.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific chemical peel market accounted for 23.6% of the global market, valued at USD 0.50 billion in 2025, and is projected to register the fastest CAGR of 9.4% during the forecast period. Rising disposable incomes, expanding aesthetic clinic networks, increasing skincare awareness, and strong consumer interest in pigmentation and complexion-related treatments are driving regional demand. Growth of medical tourism and greater accessibility of professional dermatological procedures are also supporting adoption in major Asian markets.
China's market accounted for USD 0.22 billion in 2025, making it the largest contributor among the selected Asia Pacific countries. Rapid development of aesthetic medicine services, rising spending on professional skincare, and growing demand for treatments targeting pigmentation, acne-related concerns, and uneven skin texture are supporting market expansion. Digital beauty trends and greater awareness of dermatological procedures are also influencing younger consumers.
Japan's market generated USD 0.10 billion in 2025. The country's established skincare culture and strong consumer focus on maintaining clear and even-looking skin support demand for professional aesthetic treatments. Chemical peels are used within dermatology and aesthetic settings for concerns including pigmentation, acne, photoaging, and skin texture, while consumer preference for carefully controlled and less invasive procedures supports steady adoption.
Europe chemical peel market accounted for 27.1% of the global market, reaching USD 0.58 billion in 2025, and is projected to register a CAGR of 7.0% during the forecast period. A well-developed dermatology sector, growing aesthetic treatment adoption, and increasing consumer attention to skin health are supporting regional growth. Demand for professional treatments addressing pigmentation, photoaging, uneven texture, and acne-related skin concerns continues to encourage clinics to broaden their aesthetic skincare services.
Germany's market accounted for USD 0.16 billion in 2025, making it a major contributor in Europe. The country's established dermatology and aesthetic medicine infrastructure supports demand for professionally administered skin resurfacing procedures. Consumers seeking treatments for pigmentation, sun-damaged skin, uneven texture, and visible signs of aging continue to support the use of chemical peels.
The UK market was valued at USD 0.13 billion in 2025. Growing consumer interest in non-surgical cosmetic treatments, expanding medical aesthetic services, and greater awareness of professional skincare procedures are supporting market development. Chemical peels remain a commonly considered option for consumers looking to improve skin texture, pigmentation, acne-related marks, and signs of photoaging.
Latin America chemical peel market accounted for 6.5% of the global market, reaching USD 0.14 billion in 2025, and is projected to grow at a CAGR of 8.1% during the forecast period. Strong interest in aesthetic procedures, expanding dermatology services, increasing disposable incomes in major urban centers, and growing awareness of professional skincare treatments support regional development. Demand is particularly visible for procedures addressing pigmentation, acne-related marks, sun damage, and signs of aging.
Brazil's market was valued at USD 0.08 billion in 2025, making it a major contributor in Latin America. The country's established cosmetic procedure culture and extensive network of dermatology and aesthetic clinics create favorable conditions for chemical peel treatments. Consumer interest in facial rejuvenation, pigmentation management, acne-related treatments, and improving overall skin appearance continues to support demand.
Middle East & Africa chemical peel market accounted for 4.4% of the global market, totaling USD 0.09 billion in 2025, and is projected to grow at a CAGR of 7.6% during the forecast period. Expansion of premium aesthetic clinics, increasing disposable incomes in Gulf countries, medical tourism, and growing consumer interest in advanced skincare treatments are supporting market development. Demand for professional procedures targeting pigmentation, uneven skin tone, acne-related concerns, and photoaging is gradually increasing.
The UAE market was valued at USD 0.03 billion in 2025. A well-developed medical aesthetics sector, high consumer spending on beauty and personal care, and the presence of internationally oriented dermatology and cosmetic clinics support demand. Dubai and Abu Dhabi have become important destinations for aesthetic services, while growing interest in minimally invasive facial treatments continues to strengthen the country's chemical peel market.
The global chemical peel industry is moderately fragmented, with professional skincare brands, dermatology-focused companies, aesthetic treatment providers, and cosmetic manufacturers competing across superficial, medium-depth, and specialized peel solutions. Major players in the industry include PCA SKIN, VI Peel by Vitality Institute, Obagi Medical, Dermalogica, IMAGE Skincare, SkinCeuticals, and others.
Industry participants are focusing on advanced exfoliating formulations, multi-acid combinations, professional-grade treatments, and gentler solutions that address concerns such as acne, uneven skin tone, pigmentation, fine lines, and skin texture. Companies are also expanding beyond traditional in-clinic facial peels by developing at-home products and treatments for specific areas of the body, making chemical exfoliation more accessible to a wider range of consumers.
PCA SKIN: A Leading Market Player
PCA SKIN is a professional skincare brand with more than 35 years of experience in chemical peels and clinically backed skin treatments. The company serves more than 13,000 medical and aesthetic practices, while its professional treatments and daily skincare products are available in over 35 countries. Its established presence among dermatologists and estheticians has helped the brand maintain a strong position in professional exfoliation and skin health solutions.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Scar Treatment Market Size, Share, Growth, Analysis, Report, 2034
Short-Acting Insulin Market Size, Share, Growth, Analysis, 2034
Thalassemia Treatment Market Size, Share, Growth, Analysis, 2034
Rare Disease Treatment Market Size, Share, Growth, Analysis, 2034
Lyophilized Injectables Market Size, Share, Growth, Analysis, 2034
Cancer Vaccines Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com